Kirsteen Donaldson, FFPM, DM, FRCP

Consultant
Jade Consultants (Cambridge) Limited, United Kingdom

Poster(s):

• (T1330-02-12) A Phase 1, Open-Label, Drug-Drug Interaction Study Designed to Evaluate the Effect of Relacorilant on the Pharmacokinetics of the Sensitive P-gp Substrate Dabigatran Etexilate in Healthy Subjects
  Tuesday, October 22, 2024

  1:30 PM – 2:30 PM MT